Lymphokine activated killer (LAK) cells in antibody dependent cellular cytotoxicity (ADCC) using MAb 17-1A: a combination of potential usefulness in tumor therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples